Opium (Opioid) Addiction (Central Nervous System) - Drugs In Development, 2021
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Opium (Opioid) Addiction - Drugs In Development, 2021, provides an overview of the Opium (Opioid) Addiction (Central Nervous System) pipeline landscape.Opioid Addiction develops after using opioids regularly for a period of time. Prolonged use of opiates can lead to nerve damage within the brain that causes cells to stop producing endogenous opiates (natural painkillers known as endorphins). This can lead to an inability for the body to stop pain because there are no endorphins to mask the pain initially. The degeneration of the nerve cells that reduce pain can lead to a physical dependence on opiates as an external supply source. Signs and symptoms include increased general anxiety, euphoria, psychosis, depression, high blood pressure, decreased appetite, physical agitation, difficulty sleeping and pain in the bones. The predisposing factors include age, a personal history of substance abuse, and family history of substance abuse, cigarette dependency and psychologic stress.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Opium (Opioid) Addiction - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Opium (Opioid) Addiction (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Opium (Opioid) Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Opium (Opioid) Addiction and features dormant and discontinued projects.
The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 10, 13, 2, 34, 11 and 5 respectively. Similarly, the Universities portfolio in Phase II, Phase I and Preclinical stages comprises 2, 1 and 6 molecules, respectively.Opium (Opioid) Addiction (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Opium (Opioid) Addiction (Central Nervous System).- The pipeline guide reviews pipeline therapeutics for Opium (Opioid) Addiction (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.- The pipeline guide reviews key companies involved in Opium (Opioid) Addiction (Central Nervous System) therapeutics and enlists all their major and minor projects.- The pipeline guide evaluates Opium (Opioid) Addiction (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.- The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Opium (Opioid) Addiction (Central Nervous System)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.- Find and recognize significant and varied types of therapeutics under development for Opium (Opioid) Addiction (Central Nervous System).- Classify potential new clients or partners in the target demographic.- Develop tactical initiatives by understanding the focus areas of leading companies.- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.- Formulate corrective measures for pipeline projects by understanding Opium (Opioid) Addiction (Central Nervous System) pipeline depth and focus of Indication therapeutics.- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Opium (Opioid) Addiction (Central Nervous System) - Drugs In Development, 2021
Table of Contents
Introduction
Opium (Opioid) Addiction - Overview
Opium (Opioid) Addiction - Therapeutics Development
Opium (Opioid) Addiction - Therapeutics Assessment
Opium (Opioid) Addiction - Companies Involved in Therapeutics Development
Opium (Opioid) Addiction - Drug Profiles
Opium (Opioid) Addiction - Dormant Projects
Opium (Opioid) Addiction - Discontinued Products
Opium (Opioid) Addiction - Product Development Milestones
Appendix
List of Tables
Number of Products under Development for Opium (Opioid) Addiction, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Number of Products under Development by Companies, 2021 (Contd..2)
Number of Products under Development by Companies, 2021 (Contd..3)
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Products under Development by Companies, 2021 (Contd..3)
Products under Development by Companies, 2021 (Contd..4)
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Target, 2021 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Mechanism of Action, 2021 (Contd..1)
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Opium (Opioid) Addiction - Pipeline by Adial Pharmaceuticals Inc, 2021
Opium (Opioid) Addiction - Pipeline by Alar Pharmaceuticals Inc, 2021
Opium (Opioid) Addiction - Pipeline by Amygdala Neurosciences Inc, 2021
Opium (Opioid) Addiction - Pipeline by Antheia Inc, 2021
Opium (Opioid) Addiction - Pipeline by Aoxing Pharmaceutical Company Inc, 2021
Opium (Opioid) Addiction - Pipeline by Aphios Corp, 2021
Opium (Opioid) Addiction - Pipeline by Aquilus Pharmaceuticals Inc, 2021
Opium (Opioid) Addiction - Pipeline by Astellas Pharma Inc, 2021
Opium (Opioid) Addiction - Pipeline by Atai Life Sciences BV, 2021
Opium (Opioid) Addiction - Pipeline by Benuvia Therapeutics Inc, 2021
Opium (Opioid) Addiction - Pipeline by BioCorRx Inc, 2021
Opium (Opioid) Addiction - Pipeline by BioXcel Therapeutics Inc, 2021
Opium (Opioid) Addiction - Pipeline by Bridge Therapeutics Inc, 2021
Opium (Opioid) Addiction - Pipeline by Bright Minds Biosciences Inc, 2021
Opium (Opioid) Addiction - Pipeline by Camurus AB, 2021
Opium (Opioid) Addiction - Pipeline by Cessation Therapeutics LLC, 2021
Opium (Opioid) Addiction - Pipeline by Closed Loop Medicine Ltd, 2021
Opium (Opioid) Addiction - Pipeline by Daisy Pharma Inc, 2021
Opium (Opioid) Addiction - Pipeline by Delpor Inc, 2021
Opium (Opioid) Addiction - Pipeline by DemeRx Inc, 2021
Opium (Opioid) Addiction - Pipeline by DMK Pharmaceuticals Inc, 2021
Opium (Opioid) Addiction - Pipeline by Elysium Therapeutics Inc, 2021
Opium (Opioid) Addiction - Pipeline by Emergent BioSolutions Inc, 2021
Opium (Opioid) Addiction - Pipeline by Ensysce Biosciences Inc, 2021
Opium (Opioid) Addiction - Pipeline by Eolas Therapeutics Inc, 2021
Opium (Opioid) Addiction - Pipeline by Epiodyne Inc, 2021
Opium (Opioid) Addiction - Pipeline by Ethismos Research Inc, 2021
Opium (Opioid) Addiction - Pipeline by Exxel Pharma Inc, 2021
Opium (Opioid) Addiction - Pipeline by Fab'entech SA, 2021
Opium (Opioid) Addiction - Pipeline by Fannin Partners LLC, 2021
Opium (Opioid) Addiction - Pipeline by Gilgamesh Pharmaceuticals Inc, 2021
Opium (Opioid) Addiction - Pipeline by Hunan Saiao Pharmaceutical Co Ltd, 2021
Opium (Opioid) Addiction - Pipeline by Indivior Plc, 2021
Opium (Opioid) Addiction - Pipeline by Inimmune Corp, 2021
Opium (Opioid) Addiction - Pipeline by Jazz Pharmaceuticals Plc, 2021
Opium (Opioid) Addiction - Pipeline by Kinoxis Therapeutics Pty Ltd, 2021
Opium (Opioid) Addiction - Pipeline by Lyndra Therapeutics Inc., 2021
Opium (Opioid) Addiction - Pipeline by Mayne Pharma Group Ltd, 2021
Opium (Opioid) Addiction - Pipeline by Mebias Discovery LLC, 2021
Opium (Opioid) Addiction - Pipeline by Mind Medicine MindMed Inc, 2021
Opium (Opioid) Addiction - Pipeline by Nirsum Laboratories Inc, 2021
Opium (Opioid) Addiction - Pipeline by Omeros Corp, 2021
Opium (Opioid) Addiction - Pipeline by Opiant Pharmaceuticals Inc, 2021
Opium (Opioid) Addiction - Pipeline by Orexo AB, 2021
Opium (Opioid) Addiction - Pipeline by Orphomed Inc, 2021
Opium (Opioid) Addiction - Pipeline by Osmotica Pharmaceutical Corp, 2021
Opium (Opioid) Addiction - Pipeline by OYE Therapeutics Inc, 2021
Opium (Opioid) Addiction - Pipeline by Palisades Therapeutics, 2021
Opium (Opioid) Addiction - Pipeline by Pharmazz Inc, 2021
Opium (Opioid) Addiction - Pipeline by Phoenix PharmaLabs Inc, 2021
Opium (Opioid) Addiction - Pipeline by Plumb Pharmaceuticals LLC, 2021
Opium (Opioid) Addiction - Pipeline by Revive Therapeutics Ltd, 2021
Opium (Opioid) Addiction - Pipeline by SafeRX Pharmaceuticals Inc, 2021
Opium (Opioid) Addiction - Pipeline by Sen-Jam Pharmaceutical LLC, 2021
Opium (Opioid) Addiction - Pipeline by Senzer Ltd, 2021
Opium (Opioid) Addiction - Pipeline by Serina Therapeutics Inc, 2021
Opium (Opioid) Addiction - Pipeline by Syntropharma Ltd, 2021
Opium (Opioid) Addiction - Pipeline by Titan Pharmaceuticals Inc, 2021
Opium (Opioid) Addiction - Pipeline by VDM Biochemicals Inc, 2021
Opium (Opioid) Addiction - Pipeline by Vivreon Biosciences LLC, 2021
Opium (Opioid) Addiction - Pipeline by Yichang Humanwell Pharmaceutical Co Ltd, 2021
Opium (Opioid) Addiction - Pipeline by Zynerba Pharmaceuticals Inc, 2021
Opium (Opioid) Addiction - Dormant Projects, 2021
Opium (Opioid) Addiction - Dormant Projects, 2021 (Contd..1)
Opium (Opioid) Addiction - Discontinued Products, 2021
List of Figures
Number of Products under Development for Opium (Opioid) Addiction, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Top 10 Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021
Central Nervous System Disorder Drugs Industry Forecasts - China Focus
Published: 27-Nov-2023 Price: US 1800 Onwards Pages: 116
This study focuses on China's Central Nervous System Disorder Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of g......
Central Nervous System Disorder Drugs Companies in China
Published: 27-Nov-2023 Price: US 1800 Onwards Pages: 48
This study focuses on China's Central Nervous System Disorder Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market fo......
Central Nervous System Disorder Drugs Markets in China
Published: 27-Nov-2023 Price: US 4000 Onwards Pages: 214
China's demand for Central Nervous System Disorder Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, in......
Global Drugs of Nervous System Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 14-Nov-2023 Price: US 3380 Onwards Pages: 108
Market Overview of Global Drugs of Nervous System market:
According to our latest research, the global Drugs of Nervous System market looks promising in the next 5 years. As of 2022, the global Drugs of Nervous System market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Drugs of Nervous System are drugs used for the treatment of diseases affecting the brain or spinal cord such as epilepsy, ......
Central Nervous System Collaboration and Licensing Deals 2016-2023
Published: 01-Oct-2023 Price: US 3995 Onwards Pages: 650
Central Nervous System Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the central nervous system deals entered into by the worlds leading biopharma companies.
Fully revised and updated, the report provides details of central nervous system deals from 2016 to 2023.
The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal te......
Global Drugs of Nervous System Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 24-Feb-2023 Price: US 3260 Onwards Pages: 123
Drugs of Nervous System are drugs used for the treatment of diseases affecting the brain or spinal cord such as epilepsy, Parkinson's disease, Alzheimer's disease, depression, anxiety and bipolar disorders. Epilepsy is a chronic brain disorder characterized by recurring seizures. Parkinson's disease is a degenerative CNS disorder associated with symptoms including tremor, rigidity, akinesia and bradykinesia.
The Drugs of Nervous System market revenue was XX Million USD in 2022, and will r......
Global Drugs of Nervous System Market Research Report 2022 - Market Size, Current Insights and Development Trends
Published: 26-Jan-2023 Price: US 3450 Onwards Pages: 111
Drugs of Nervous System are drugs used for the treatment of diseases affecting the brain or spinal cord such as epilepsy, Parkinson's disease, Alzheimer's disease, depression, anxiety and bipolar disorders. Epilepsy is a chronic brain disorder characterized by recurring seizures. Parkinson's disease is a degenerative CNS disorder associated with symptoms including tremor, rigidity, akinesia and bradykinesia.
The report focuses on the Drugs of Nervous System market size, segment si......
Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published: 30-Nov-2022 Price: US 2000 Onwards Pages: 71
Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Encephalopathy - Drugs In Development, 2022, provides an overview of the Encephalopathy (Central Nervous System) pipeline landscape.
Encephalopathy is a term for any diffuse disease of the brain that alters brain function or structure. Symptoms include seizures......
Metachromatic Leukodystrophy (MLD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published: 30-Nov-2022 Price: US 2000 Onwards Pages: 40
Metachromatic Leukodystrophy (MLD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metachromatic Leukodystrophy (MLD) - Drugs In Development, 2022, provides an overview of the Metachromatic Leukodystrophy (MLD) (Central Nervous System) pipeline landscape.
Metachromatic leukodystrophy is an inherited disorder characterized ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
